| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000023903 |
| Receipt No. | R000027527 |
| Official scientific title of the study | Randomized controlled trial to reduce stress |
| Date of disclosure of the study information | 2016/09/05 |
| Last modified on | 2016/09/02 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Randomized controlled trial to reduce stress | |
| Title of the study (Brief title) | Randomized controlled trial to reduce stress
|
|
| Region |
|
|
| Condition | ||
| Condition | NA | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate efficacy of implementation of self-help stress care program and taking functional peptide-containing drink for six weeks |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Stress reaction, administered before and after the trial (6W);
the Tension-Anxiety (TA), Depression (D), and Fatigue (F) subscales of the POMS |
| Key secondary outcomes | Somatosensory Amplification Scale , Medical Symptom Checklist, General Self Efficacy Scale |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Self-help stress care program and functional peptide drink for 6 weeks everyday
|
|
| Interventions/Control_2 | Self-help stress care program for 6 weeks everyday
|
|
| Interventions/Control_3 | Placebo program for 6 weeks everyday
|
|
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy males and females aged 20 years or more.
2) Subjects who can make self-judgment and agree to participate this trial. |
|||
| Key exclusion criteria | 1)Subjects who take continuous medical treatment.
2)Subjects who are pregnant or have possibility to become pregnant or planning to become pregnant during the study or breast-feeding woman. 3)Subjects who have allergic reaction to food. 4)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons. |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Keiichi Abe |
| Organization | Suntory Global Innovation Center Ltd. |
| Division name | Innovation Development Department |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284 Japan |
| TEL | 050-3182-0433 |
| Keiichi_Abe@suntory.co.jp | |
| Public contact | |
| Name of contact person | Yuji Nonaka |
| Organization | Suntory Global Innovation Center Ltd. |
| Division name | Innovation Development Department |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284 Japan |
| TEL | 050-3182-0587 |
| Homepage URL | |
| Yuji_Nonaka@suntory.co.jp | |
| Sponsor | |
| Institute | Suntory Global Innovation Center Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Suntory Global Innovation Center Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Division of Psychosomatic Medicine, Teikyo University Hospital, Teikyo University School of Medicine
Faculty of Human Sciences, Musashino University |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://www.facebook.com/wcpmglasgow/ |
| Results | The self-help CCBT program reduced the subjective experience of tension-anxiety in workers. The addition of a supplement drink enhanced the effect of CCBT on fatigue, providing one possible approach to enhancement of such programs. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027527 |